Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China M&A To Accelerate In 2013 To Fill Gaps In Fragmented Market: KPMG Report

This article was originally published in PharmAsia News

Executive Summary

China’s drug and device industry looks set to keep up a fast pace of mergers and acquisitions in 2013 as companies see solid demand prospects and fragmented market sectors, says a KPMG report.


Related Content

Merck, Simcere Form JV To Expand Access To Lifestyle Drugs Across China


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts